Answers are grounded in this paper and cite their sources.
Continuous glucose monitoring (CGM) is transforming diabetes care, yet its use in type 2 diabetes (T2DM) remains underutilized in primary care. Given that most individuals with diabetes in Canada have T2DM and are managed primarily by primary care providers, the ability to interpret and apply CGM data is essential. This review provides an overview of CGM technology, key metrics, benefits and limitations, and offers practical tips for implementation in primary care.
No takes yet. Share an insight, caveat, or question.
Shin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: